NasdaqHealth CareHealth Care FacilitiesS&P MidCap 400
$181.08
-1.31 (-0.72%)
Close of Nov 06, 2026 · end-of-day data
ENSG 8-K filings in 2025
Every material Form 8-K Ensign filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Ensign Group reported third-quarter 2025 GAAP diluted earnings per share of $1.42, up 6.0% from the prior year, and total revenue of $1.30 billion, up 19.8%. The company raised its full-year 2025 diluted EPS and revenue guidance, which signals higher expected earnings and sales for shareholders.
Q3 GAAP diluted EPS was $1.42 versus $1.34 a year earlier; adjusted diluted EPS was $1.64, up 18.0%
Q3 total revenue was $1.30 billion, up 19.8%; GAAP net income was $83.8 million
2025 diluted EPS guidance raised to $6.48 to $6.54 from $6.34 to $6.46; revenue guidance raised to $5.05 billion to $5.07 billion from $4.99 billion to $5.02 billion
Cash on hand was $443.7 million at September 30, 2025; quarterly dividend of $0.0625 per share was paid
Christopher Christensen, the company's Board chairman, will leave the board effective September 1, 2025, and the company said his retirement is not the result of any disagreement over its operations, policies or practices. The company approved a package for him that includes accelerated vesting of equity awards, a $2,070,000 cash bonus for services from January 1 to September 1, 2025, and a health insurance premium subsidy of up to $150,000 over five years. The company also bought back his Standard Bearer shares for $287,393, and he will provide advisory services to management for up to one year at up to $100,000 per year.
Christensen's board resignation takes effect September 1, 2025; he served as chairman and has been with the company since its 1999 founding
Cash bonus of $2,070,000 for services rendered from January 1 to September 1, 2025
Company repurchased all of his Standard Bearer Healthcare REIT shares for a total of $287,393, priced by a third-party valuation firm
Health insurance premium subsidy of up to $150,000 over five years, plus advisory services fees of up to $100,000 per year
The Ensign Group reported second-quarter 2025 GAAP diluted earnings per share of $1.44, up 18.0% from the prior year quarter, and GAAP net income of $84.4 million, up 18.9%. The company raised its full-year 2025 diluted EPS guidance to $6.34 to $6.46 from $6.22 to $6.38, and its revenue guidance to $4.99 billion to $5.02 billion from $4.89 billion to $4.94 billion, which matters to shareholders because it signals higher expected profit and sales for the year.
Q2 2025 total revenue was $1.23 billion, up 18.5% from the prior year quarter.
GAAP diluted EPS was $1.44 versus $1.22 a year earlier; adjusted diluted EPS was $1.59, up 20.5%.
2025 diluted EPS guidance raised to $6.34 to $6.46; revenue guidance raised to $4.99 billion to $5.02 billion.
Cash on hand was approximately $364.0 million, with $592.6 million of available line-of-credit capacity.
Executive Chairman Christopher Christensen will retire from the board and as Executive Chairman effective September 1, 2025. Chief Executive Officer Barry Port will become Chair of the Board on the same date, and Marivic Uychiat joins the board to fill the vacancy.
Christensen's retirement from the board and as Executive Chairman is effective September 1, 2025; he was Chief Executive Officer from April 2006 until May 2019.
Barry Port, CEO since May 2019, was appointed Chair of the Board effective September 1, 2025.
Marivic S. Uychiat joins the board effective September 1, 2025, as a non-independent director; the board will have nine members, six of them independent.
Ensign Group reported first quarter 2025 GAAP diluted earnings per share of $1.37, up from $1.19 a year earlier, and revenue of $1.17 billion, up 16.1%. The company raised its full-year 2025 earnings guidance to $6.22 to $6.38 per diluted share from $6.16 to $6.34, and its revenue guidance to $4.89 billion to $4.94 billion from $4.83 billion to $4.91 billion.
GAAP diluted EPS was $1.37 versus $1.19 a year earlier; adjusted diluted EPS was $1.52 versus $1.30
Total revenue was $1.17 billion, up 16.1%, and GAAP net income was $80.3 million, up 16.6%
2025 EPS guidance raised to $6.22 to $6.38 per diluted share; revenue guidance raised to $4.89 billion to $4.94 billion
Cash on hand was approximately $282.7 million at March 31, 2025, with $572.1 million of available line-of-credit capacity
Ensign Group reported fourth-quarter and full-year 2024 results, with revenue and earnings per share both up from 2023. The company also issued 2025 guidance of $6.16 to $6.34 per diluted share and revenue of $4.83 billion to $4.91 billion, which would be higher than 2024 results based on the release's own comparison.
Full-year 2024 total revenue was $4.26 billion, up 14.2%; GAAP diluted EPS was $5.12, up 40.3%, and adjusted diluted EPS was $5.50, up 15.3%.
Fourth-quarter 2024 revenue was $1.13 billion, up 15.5%; GAAP diluted EPS was $1.36 versus $0.38 a year earlier, and adjusted diluted EPS was $1.49.
2025 guidance: diluted EPS of $6.16 to $6.34 and revenue of $4.83 billion to $4.91 billion, based on about 59.5 million diluted shares and a 25.0% tax rate.
Cash on hand was $464.6 million at year-end, with $572.1 million of available line-of-credit capacity.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Ensign filing is on SEC EDGAR ↗. 8-K briefs of other companies →